Phospholipase A2 (LP-PLA2) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-Phospholipase A2 (LP-PLA2) antibodies (anti-Phospholipase A2, anti-LP-PLA2) and diagnostic hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2), OVA-Phospholipase A2 (LP-PLA2), KLH-Phospholipase A2 (LP-PLA2) antigens for Metabolic diseases LP-PLA2 detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-SMT-LP-PLA2-Ag01 BSA-Phospholipase A2 (LP-PLA2) 756
GMP-SMT-LP-PLA2-Ag02 OVA-Phospholipase A2 (LP-PLA2) 756
GMP-SMT-LP-PLA2-Ab01 Anti-human Phospholipase A2 (LP-PLA2) mouse monoclonal antibody (mAb) 1953
GMP-SMT-LP-PLA2-Ab02 Anti-human Phospholipase A2 (LP-PLA2) human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-SMT-LP-PLA2-Ag01
Product Name BSA-Phospholipase A2 (LP-PLA2)
Target/Biomarker Phospholipase A2 (LP-PLA2)
Expression platform Synthetic
Isotypes NA
Bioactivity validation Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation.
Tag NA
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2) / OVA-Phospholipase A2 (LP-PLA2) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-LP-PLA2-Ag02
Product Name OVA-Phospholipase A2 (LP-PLA2)
Target/Biomarker Phospholipase A2 (LP-PLA2)
Expression platform Synthetic
Isotypes NA
Bioactivity validation Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation.
Tag NA
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2) / OVA-Phospholipase A2 (LP-PLA2) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-LP-PLA2-Ab01
Product Name Anti-human Phospholipase A2 (LP-PLA2) mouse monoclonal antibody (mAb)
Target/Biomarker Phospholipase A2 (LP-PLA2)
Expression platform Hybridoma
Isotypes Mouse IgG
Bioactivity validation Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation.
Tag mFc
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2) / OVA-Phospholipase A2 (LP-PLA2) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-LP-PLA2-Ab02
Product Name Anti-human Phospholipase A2 (LP-PLA2) human monoclonal antibody (mAb)
Target/Biomarker Phospholipase A2 (LP-PLA2)
Expression platform Hybridoma
Isotypes Mouse IgG
Bioactivity validation Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation.
Tag mFc
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2) / OVA-Phospholipase A2 (LP-PLA2) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    The phospholipase A2  (PLA2) family of proteins includes lipolytic enzymes that catalyze the hydrolysis of the ester bond at the sn-2 position of phospholipids to yield free fatty acids and lysophospholipids. Each member of the phospholipase A2 family of enzymes serves a distinct role in generating active lipid metabolites that promote inflammatory metabolic diseases including atherosclerosis, hyperlipidemia, obesity, and diabetes.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment